Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Droperidol vs ondansetron for akathisia risk in ambulatory postoperative nausea and vomiting prophylaxis
2013-000905-22Phase 3Completed
- Sponsor
- Strasbourg University Hospital
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of droperidol in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Strasbourg University Hospital. Primary endpoint: Incidence of akathisia in droperidol vs ondansetron arms. Started Sep 2015; status: completed.
02
Drugs
droperidol
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on 2013-000905-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000905-22.